SCHEMBL788263

SCHEMBL788263

c1ccc(-c2cc(-c3ccccc3)c3sc4c(-c5ccc6c(c5)[nH]c5cc(-c7cc(-c8ccccc8)cc8c7sc7c(-c9ccccc9)cc(-c9ccccc9)cc78)ccc56)cc(-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 3/20 0.41
CDK4 P11802 2/20 0.39
CCND1 P24385 2/20 0.39
FEN1 P39748 1/20 0.38
IMPDH2 P12268 1/20 0.38
JAK2 O60674 2/20 0.36
RHEB Q15382 1/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GPR17 Q13304 1/20 0.35
BRD4 O60885 1/20 0.34
AHR P35869 1/20 0.34
TNKS O95271 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34
CHEK1 O14757 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788279 0.96 AHR (0.42) TNKS2CDK4CCND1FEN1IMPDH2
SCHEMBL788260 0.89 CDK4 (0.40) TNKS2CDK4CCND1JAK2HPGD
SCHEMBL789896 0.89 LIMK1 (0.41) TNKS2CDK4CCND1FEN1IMPDH2
SCHEMBL788608 0.88 AHR (0.43) TNKS2CDK4CCND1HPGDSMN1; SMN2
SCHEMBL788520 0.85 AHR (0.41) TNKS2CDK4CCND1FEN1HPGD
SCHEMBL15179387 0.84 LIMK1 (0.37) TNKS2IMPDH2HPGDSMN1; SMN2HTT
SCHEMBL788246 0.83 ALOX5 (0.46) TNKS2CDK4CCND1FEN1IMPDH2
SCHEMBL10018871 0.82 ALOX5 (0.36) TNKS2JAK2SMN1; SMN2HTTALDH1A1
SCHEMBL15179495 0.81 HSD17B1 (0.37) TNKS2IMPDH2JAK2SMN1; SMN2HTT
SCHEMBL788285 0.81 AHR (0.44) TNKS2CDK4CCND1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450188-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-09-20 US disclosed
US-20140145175-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-29 US disclosed
US-8642782-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 US disclosed
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SLC39A3, SULT1A1, NUTF2 TNKS2 3776/4885CDK4 194/4885CCND1 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.